CSI Market
Sign In | Register

Axonics Inc (AXNX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access AXNX quarterly Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Axonics Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Operating Activities
Income-6.09
Depreciation & amortization12.49
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability2.40
Provision For Loan Losses Expensed0.12
Increase (Decrease) in Inventories-25.75
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation44.54
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
In Process Research And Development Expense15.45
Increase Decrease In Operating Lease Liability0.03
Payment For Contingent Consideration Liability Operating Activities-27.37
Income taxes-6.57
Losses/ -gains on Investments net0.00
Accounts Receivable-12.88
Increase (Decrease) in Accounts Payable9.01
Increase (Decrease) in Accrued Liabilities3.89
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-10.40
Other Working Capital-2.63
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.76
Discontinued operations0.00
Net Cash flow from Operating Activities-2.02
Investing Activities
Capital Expenditures-3.55
Sale of Capital Items0.00
Short-term Investments Proceeds-113.35
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-116.90
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.25
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-7.63
Proceeds From Issuance Of Preferred Stock And Preference Stock And Noncontrolling Interest-
Stock Issued-
Warrants Issued Debt Issuance Costs-
Accrued Loan Fees Debt Issuance Costs-
Forgiveness of Stock Subscription Receivable-
Stock Issued During Period Value Acquisitions-
Noncash Or Part Noncash Acquisition Contingent Consideration-
Stock Issued During Period Value Exclusive License Asset-
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-3.38
Effect of exchange rate on cash flow0.98
Discontinued operations0.00
Free Cash Flow-5.57
Total Cash Flow-121.32
4 historic quarters locked

Sign in to unlock the full Axonics Inc cash flow history.

Sign In Create Free Account

About Axonics Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: February 28, 2024
  • Source: axnx-20231231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001603756-24-000036

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License